Medicare Enrolled
Dr. Aamir Iqbal, MD
Nephrology · Shelby, NC
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Iqbal from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Iqbal?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Iqbal
Dr. Aamir Iqbal is a nephrology specialist in Shelby, NC, with 19 years of NPI registration. Based on federal Medicare data, Dr. Iqbal performed 8,126 Medicare services across 5,283 unique beneficiaries.
Between the years covered by Open Payments, Dr. Iqbal received a total of $3,158 from 25 pharmaceutical and/or device companies across 208 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nephrology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Iqbal is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 8% volume in NC
$3,158 industry payments
Medicare Practice Summary
Medicare Utilization ↗8,126
Medicare services
Top 8% in NC for nephrology
5,283
Unique beneficiaries
$26
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~428 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
682 | $8 | $18 |
| Urine microalbumin test (kidney screening) A laboratory test that measures the amount of microalbumin, a small protein, in a urine sample. This test is used to detect early signs of kidney damage. |
577 | $6 | $30 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
550 | $8 | $47 |
| Creatinine test (kidney function) A blood test that measures the amount of creatinine to assess kidney function or detect muscle injury. |
542 | $5 | $31 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
523 | $85 | $702 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
440 | $88 | $661 |
| Parathyroid hormone level test A blood test that measures the amount of parathyroid hormone in your body. This hormone helps regulate calcium levels in the blood and bones. |
435 | $40 | $248 |
| Uric acid level test A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines. |
426 | $4 | $27 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
417 | $2 | $14 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
412 | $45 | $344 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
369 | $35 | $265 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
340 | $29 | $178 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
322 | $10 | $63 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
302 | $34 | $262 |
| Kidney function blood test panel | 281 | $8 | $52 |
| Cystatin C level test A blood test that measures the level of cystatin C, a protein produced by cells in the body. This measurement is used to help assess kidney function. |
281 | $18 | $111 |
| Annual depression screening | 191 | $17 | $100 |
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
153 | $3 | $19 |
| Phosphate level test A blood test that measures the amount of phosphate in your body. Phosphate is a mineral that helps keep bones and teeth strong. |
140 | $5 | $28 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
108 | $59 | $441 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
86 | $29 | $217 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
76 | $89 | $721 |
| Complement and antigen measurement A laboratory test to measure levels of complement proteins and antigens in the blood. |
67 | $12 | $73 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
51 | $6 | $40 |
| Remote physiologic monitoring setup and education Initial setup of remote monitoring equipment and patient education on its use. |
51 | $13 | $100 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
49 | $8 | $52 |
| Iron level test | 48 | $6 | $39 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
47 | $13 | $82 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
37 | $116 | $914 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
29 | $59 | $495 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
23 | $36 | $260 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
22 | $15 | $90 |
| Folic acid level test A blood test that measures the amount of folic acid in the serum. |
21 | $14 | $88 |
| Urine total protein level A laboratory test that measures the total amount of protein present in a urine sample. |
14 | $4 | $22 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
14 | $54 | $457 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$3,158
Total received (2018-2024)
Avg $451/year across 7 years
Top 29% in NC for nephrology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
25
Companies
208
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,038 (96.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$120 (3.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,214
2023
$747
2022
$626
2021
$292
2020
$60
2019
$111
2018
$108
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
OPKO Pharmaceuticals, LLC
$406
Amgen Inc.
$200
Otsuka America Pharmaceutical, Inc.
$127
Travere Therapeutics, Inc.
$96
CALLIDITAS THERAPEUTICS US INC.
$63
Novartis Pharmaceuticals Corporation
$62
AstraZeneca Pharmaceuticals LP
$44
Mallinckrodt Hospital Products Inc.
$43
Bayer Healthcare Pharmaceuticals Inc.
$40
Lilly USA, LLC
$36
Aurinia Pharma U.S., Inc.
$21
GlaxoSmithKline, LLC.
$21
Vifor Pharma, Inc.
$19
Fresenius USA Marketing, Inc.
$18
Boehringer Ingelheim Pharmaceuticals, Inc.
$17
Top 3 companies account for 60.4% of 2024 payments
All-time payments by company (2018-2024) ›
OPKO Pharmaceuticals, LLC
$811
AstraZeneca Pharmaceuticals LP
$338
Amgen Inc.
$304
Otsuka America Pharmaceutical, Inc.
$289
Mallinckrodt Hospital Products Inc.
$198
Aurinia Pharma U.S., Inc.
$180
Vifor Pharma, Inc.
$116
Bayer HealthCare Pharmaceuticals Inc.
$114
GlaxoSmithKline, LLC.
$103
Travere Therapeutics, Inc.
$96
Mallinckrodt Enterprises LLC
$83
Bayer Healthcare Pharmaceuticals Inc.
$79
CALLIDITAS THERAPEUTICS US INC.
$79
Novartis Pharmaceuticals Corporation
$78
Horizon Therapeutics plc
$58
Lilly USA, LLC
$36
Fresenius USA Marketing, Inc.
$34
Keryx Biopharmaceuticals, Inc.
$31
Relypsa, Inc.
$30
Circassia Pharmaceuticals Inc
$29
Boehringer Ingelheim Pharmaceuticals, Inc.
$17
Shield Therapeutics Inc
$16
Horizon Pharma plc
$13
Allergan Inc.
$13
Alexion Pharmaceuticals, Inc.
$12
Top 3 companies account for 46.0% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · ACTHAR · ANDEXXA · Aranesp · Auryxia · BENLYSTA · FARXIGA · Fabhalta · JARDIANCE · JYNARQUE · KRYSTEXXA · Kerendia · LINZESS · LOKELMA · LUPKYNIS · NIOX VERO · Parsabiv · RAYALDEE · Rayaldee · TARPEYO · TAVNEOS · Velphoro · Veltassa
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Nephrologists within 10 mi
11
Per 100K population
11.0
County median income
$55,769
Nearest hospital
ATRIUM HEALTH CLEVELAND
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Iqbal is a clinical cardiology specialist, with above-average Medicare volume (top 8% in NC), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Iqbal experienced with blood draw (venipuncture)?
Based on Medicare claims data, Dr. Iqbal performed 682 blood draw (venipuncture) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Iqbal receive payments from pharmaceutical companies?
Yes. Dr. Iqbal received a total of $3,158 from 25 companies across 208 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Iqbal's costs compare to other nephrologists in Shelby?
Dr. Iqbal's average Medicare payment per service is $26. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Iqbal) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Nephrology
Common procedures, typical costs, and what industry payments mean in nephrology.
Same specialty & city
Nephrologists in Shelby
Browse nephrologists in Shelby ranked by procedure volume and transparency data.
Highest volume
Top Nephrologists in NC
Nephrologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Nephrologists in NC
Which NC nephrologists receive the most from drug and device companies.
By company
OPKO Pharmaceuticals, LLC Payments to Doctors
See all physicians who received payments from OPKO Pharmaceuticals, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology